TGFB1 and breast carcinoma: In contrast, BMP-2/7 heterodimer, which acts as a powerful antagonist of TGF-β signalling pathway-induced EMT programme and invasiveness of breast cancer cells, strongly reduced the number of ALDHhigh/CD44high/CD24−/low BCSCs and bone metastases [262].